Academic literature on the topic 'Lentivirusus'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lentivirusus.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Lentivirusus"
Clements, J. E., and M. C. Zink. "Molecular biology and pathogenesis of animal lentivirus infections." Clinical Microbiology Reviews 9, no. 1 (January 1996): 100–117. http://dx.doi.org/10.1128/cmr.9.1.100.
Full textLairmore, M. D., S. T. Butera, G. N. Callahan, and J. C. DeMartini. "Spontaneous interferon production by pulmonary leukocytes is associated with lentivirus-induced lymphoid interstitial pneumonia." Journal of Immunology 140, no. 3 (February 1, 1988): 779–85. http://dx.doi.org/10.4049/jimmunol.140.3.779.
Full textHötzel, Isidro, and William P. Cheevers. "Conservation of Human Immunodeficiency Virus Type 1 gp120 Inner-Domain Sequences in Lentivirus and Type A and B Retrovirus Envelope Surface Glycoproteins." Journal of Virology 75, no. 4 (February 15, 2001): 2014–18. http://dx.doi.org/10.1128/jvi.75.4.2014-2018.2001.
Full textArmimi, Anastasia, Afina Firdaus Syuaib, Katherine Vanya, Marselina Irasonia Tan, Dessy Natalia, David Virya Chen, Chikako Ono, Yoshiharu Matsuura, Anita Artarini, and Ernawati Arifin Giri-Rachman. "SARS-CoV-2 Neutralization Assay System using Pseudo-lentivirus." Indonesian Biomedical Journal 15, no. 2 (April 18, 2023): 179–86. http://dx.doi.org/10.18585/inabj.v15i2.2212.
Full textCourgnaud, Valérie, Xavier Pourrut, Frédéric Bibollet-Ruche, Eitel Mpoudi-Ngole, Anke Bourgeois, Eric Delaporte, and Martine Peeters. "Characterization of a Novel Simian Immunodeficiency Virus from Guereza Colobus Monkeys (Colobus guereza) in Cameroon: a New Lineage in the Nonhuman Primate Lentivirus Family." Journal of Virology 75, no. 2 (January 15, 2001): 857–66. http://dx.doi.org/10.1128/jvi.75.2.857-866.2001.
Full textBrowning, Matthew T., Russell D. Schmidt, Kathy A. Lew, and Tahir A. Rizvi. "Primate and Feline Lentivirus Vector RNA Packaging and Propagation by Heterologous Lentivirus Virions." Journal of Virology 75, no. 11 (June 1, 2001): 5129–40. http://dx.doi.org/10.1128/jvi.75.11.5129-5140.2001.
Full textChen, Jianbo, Douglas Powell, and Wei-Shau Hu. "High Frequency of Genetic Recombination Is a Common Feature of Primate Lentivirus Replication." Journal of Virology 80, no. 19 (October 1, 2006): 9651–58. http://dx.doi.org/10.1128/jvi.00936-06.
Full textBaccam, Prasith, Robert J. Thompson, Yuxing Li, Wendy O. Sparks, Michael Belshan, Karin S. Dorman, Yvonne Wannemuehler, J. Lindsay Oaks, James L. Cornette, and Susan Carpenter. "Subpopulations of Equine Infectious Anemia Virus Rev Coexist In Vivo and Differ in Phenotype." Journal of Virology 77, no. 22 (November 15, 2003): 12122–31. http://dx.doi.org/10.1128/jvi.77.22.12122-12131.2003.
Full textNarayan, O., D. Sheffer, J. E. Clements, and G. Tennekoon. "Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages." Journal of Experimental Medicine 162, no. 6 (December 1, 1985): 1954–69. http://dx.doi.org/10.1084/jem.162.6.1954.
Full textKafri, Tal, Henriette van Praag, Ling Ouyang, Fred H. Gage, and Inder M. Verma. "A Packaging Cell Line for Lentivirus Vectors." Journal of Virology 73, no. 1 (January 1, 1999): 576–84. http://dx.doi.org/10.1128/jvi.73.1.576-584.1999.
Full textDissertations / Theses on the topic "Lentivirusus"
Robertson, David L. "Recombination in primate lentiviruses." Thesis, University of Nottingham, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336866.
Full textVödrös, Dalma. "Receptor use of primate lentiviruses /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-497-6/.
Full textBailes, Elizabeth. "Origins and evolution of primate lentiviruses." Thesis, University of Nottingham, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.246384.
Full textCordeil, Stéphanie. "Etude de la différence de susceptibilité des lentivirus de primates aux interférons de type I." Thesis, Lyon, École normale supérieure, 2012. http://www.theses.fr/2012ENSL0781.
Full textType I Interferons (IFN-α/β, herein IFNs) provide an important mechanism of defense against pathogens and regulate in a paracrine and autocrine manner both intrinsic and adaptive immune responses. In the case of HIV-1 however, the relationship between IFNs and viral replication appears more complex. Indeed, if IFNs have been described to interfere with HIV-1 at basically all phases of its life cycle ex vivo, an IFN-induced state is linked to AIDS progression and to high viral loads in HIV-1 infected individuals. Similarly, a deregulated and prolonged IFN production/state seems one of the main distinguishing features between pathogenic and non-pathogenic SIV infection in primate animal models, suggesting that a deregulated IFN-state may be more detrimental to the host than to the virus itself in vivo.If this hypothesis is correct and if HIV-1 plays an active role in the perpetration of this antiviral state, it is possible that HIV-1 may have overall evolved to cope with this environment, remaining able to replicate despite it.To determine whether HIV-1 was better armed to replicate in the presence of an IFN-state environment than other primate lentiviruses, we compared HIV-1 to SIVmac and more importantly to HIV-2 that albeit capable of inducing AIDS in humans does so in a much less aggressive manner. In agreement with the initial hypothesis, our results indicate that HIV-1 is better fit to replicate in primary cells in the presence of amounts of IFN comparable to the ones measured in vivo, while the replication of HIV-2/SIVmac viruses is completely blocked even in the presence of low levels of IFN. By decorticating the effects of IFNs on the early and late phases of the viral life cycle in primary macrophages, we show here that the main target of the differential action of IFNs are the early phases of infection. More specifically, with time kinetics that we determine herein, IFNs induce cellular factor/s that differentially affect the stability of pre-reverse transcription complexes of HIV-2, but not of HIV-1. Our results could underlie a different evolutionary adaptation of primate lentiviruses to interferons that might be responsible for their different pathogenicity in vivo
Gelinas, Jean-Francois. "Enhancement of lentiviral vector production through alteration of virus-cell interactions." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:9921b8b4-e2b5-4eec-9efc-6036765c8d55.
Full textKelly, Maureen C. "Parallels in tRNA primer acquisition by lentiviruses." Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2007. https://www.mhsl.uab.edu/dt/2009r/kelly.pdf.
Full textMartin, Michaël. "Mécanisme moléculaire de l'antagonisme du complexe HUSH par les protéines lentivirales Vpx et Vpr." Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5160.
Full textHIV-1 and HIV-2, lentiviruses responsible for AIDS, appeared in humans after cross-species transmissions from simian viruses (SIV). In addition to their structural and regulatory proteins, lentiviruses encode auxiliary proteins that promote viral replication in the host cell by counteracting antiviral cellular factors, called restriction factors. The mechanism of action of these viral auxiliary proteins often relies on the hijacking of Ubiquitin-Ligase complexes, a mechanism widely used by various pathogens, to degrade host cell proteins. This mechanism is used by the Vpx protein, expressed only by HIV-2 (and not by HIV-1), which induces the degradation of SAMDH1, a restriction factor blocking the reverse transcription step. Thus, Vpx molecularly bridges the DCAF1 adaptor of the Cul4A-DDB1(DCAF1) Ubiquitin-Ligase complex with SAMHD1, resulting in ubiquitination and degradation of SAMHD1. In 2018, our team showed that Vpx induces the degradation of an additional cellular factor: the HUSH complex, composed of TASOR, MPP8 and Periphilin. This complex is involved in the epigenetic repression not only of many cellular genes, retro-transposable elements and endogenous retroviruses, but also of the HIV genome integrated into the infected cell. By degrading HUSH, Vpx promotes viral expression. In this context, the objectives of my thesis were to: (i) Determine whether HUSH degradation mechanism induced by HIV-2 Vpx was identical to SAMHD1 degradation mechanism. I was able to highlight important differences between the two mechanisms although Vpx uses, in both cases, the same Ubiquitin-Ligase adaptor, DCAF1 (main focus of the thesis work, submitted article). (ii) Characterize the molecular determinants involved in the antagonism of HUSH by other lentiviral proteins. First, we wanted to know if different Vpx-related viral proteins, in various simian virus species, had the same capacity to degrade the HUSH complex. This allowed us to reveal a lentiviral species-specificity of HUSH complex antagonism, a major characteristic of restriction factors (contribution to Chougui et al., Nature microbiology, 2018). Secondly, this led me to start studying the viral determinants of these Vpx-related proteins, such as the Vpr proteins from different strains of SIVagm (infecting the African green monkey) that present different phenotypes regarding both SAMHD1 or HUSH degradation (work in progress). All the results allowed us to better characterize the mechanism of HUSH antagonism by Vpx/Vpr lentiviral proteins, and to provide the first molecular tools to differentiate HUSH antagonism from SAMHD1 antagonism in primary cells. In the future, these data may help to better understand how various lentiviral proteins have adapted to their different cellular substrates (and vice versa) along evolution. Finally, targeting HUSH through the identification of interaction or degradation determinants could be interesting for the development of new therapeutic targets
Li, Li. "Short-term and long-term evolution of lentiviruses." Thesis, University of Nottingham, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.575475.
Full textLee, Wei-Cheng. "Studies on lentivirus infection of macrophages." Thesis, University of Edinburgh, 1994. http://hdl.handle.net/1842/29845.
Full textStarling, Isabella. "Mechanisms and specificity of lentivirus neurotoxicity." Thesis, University of Edinburgh, 1998. http://webex.lib.ed.ac.uk/abstracts/starli01.pdf.
Full textBooks on the topic "Lentivirusus"
Maurizio, Federico, ed. Lentivirus gene engineering protocols. Totowa, N.J: Humana Press, 2003.
Find full textmissing], [name. Lentivirus gene engineering protocols. Totowa, NJ: Humana Press, 2003.
Find full textMaurizio, Federico, ed. Lentivirus gene engineering protocols. 2nd ed. New York: Humana Press, 2010.
Find full textFederico, Maurizio, ed. Lentivirus Gene Engineering Protocols. Totowa, NJ: Humana Press, 2003. http://dx.doi.org/10.1385/1592593933.
Full textFederico, Maurizio, ed. Lentivirus Gene Engineering Protocols. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-533-0.
Full textE, Wilcox G., Soeharsono S, Dharma D. M. N, Copland J. W, AustralianCentre for International Agricultural Research., Indonesia Direktorat Jenderal Petermakan, and Bali Cattle Disease Investigation Unit., eds. Jembrana disease and the bovine lentiviruses: Proceedings of a workshop 10-13 June 1996, Bali, Indonesia. Canberra: Australian Centre for International Agricultural Research in association with Direktorat Jenderal Petermakan and the Bali Cattle Disease Investigation Unit, 1997.
Find full textMilne, Catherine E. Maedi visna: The disease, its potential impact on the UK sheep industry and a cost benefit appraisal ofcontrol strategies. [Aberdeen]: SAC, 1993.
Find full text1949-, Morrow John, and Haigwood Nancy L, eds. HIV molecular organization, pathogenicity, and treatment. Amsterdam: Elsevier, 1993.
Find full text1963-, Sobo Elisa Janine, ed. The endangered self: Managing the social risk of HIV. London: Routledge, 2000.
Find full textNichols, Eve K. Expanding access to investigational therapies for HIV infection and AIDS: March 12-13, 1990, conference summary. Washington, D.C: National Academy Press, 1991.
Find full textBook chapters on the topic "Lentivirusus"
Federico, Maurizio. "From Lentiviruses to Lentivirus Vectors." In Lentivirus Gene Engineering Protocols, 3–15. Totowa, NJ: Humana Press, 2003. http://dx.doi.org/10.1385/1-59259-393-3:3.
Full textLu, Yichen, and Max Essex. "Lentivirus‡." In The Springer Index of Viruses, 1693–702. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-95919-1_275.
Full textGonda, Matthew A. "The Lentiviruses of Cattle." In The Retroviridae, 83–109. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-1730-0_3.
Full textPlanelles, Vicente. "Hybrid Lentivirus Vectors." In Lentivirus Gene Engineering Protocols, 273–84. Totowa, NJ: Humana Press, 2003. http://dx.doi.org/10.1385/1-59259-393-3:273.
Full textSurdziel, Ewa, Matthias Eder, and Michaela Scherr. "Lentivirus-Mediated Antagomir Expression." In Methods in Molecular Biology, 237–48. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-811-9_16.
Full textFultz, P. N. "SIVsmmPBj14: An Atypical Lentivirus." In Current Topics in Microbiology and Immunology, 65–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78536-8_4.
Full textZhao, Jing, and Andrew M. L. Lever. "Lentivirus-Mediated Gene Expression." In Methods in Molecular Biology, 343–55. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-030-0_20.
Full textBenskey, Matthew J., and Fredric P. Manfredsson. "Lentivirus Production and Purification." In Gene Therapy for Neurological Disorders, 107–14. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3271-9_8.
Full textDreyer, Jean-Luc. "Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions." In Lentivirus Gene Engineering Protocols, 3–35. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-533-0_1.
Full textCoppola, Valeria, Cesare Galli, Maria Musumeci, and Désirée Bonci. "Manipulating the Cell Differentiation Through Lentiviral Vectors." In Lentivirus Gene Engineering Protocols, 149–60. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-533-0_10.
Full textConference papers on the topic "Lentivirusus"
Xiao, Yun-Feng. "Label-free Detection of Single Nanoparticles and Lentiviruses Using an Optical Microcavity." In Optical Sensors. Washington, D.C.: OSA, 2013. http://dx.doi.org/10.1364/sensors.2013.st2b.3.
Full textHoffman, Robert M., Hiroyuki Kishimoto, and Toshiyoshi Fujiwara. "Specific in vivo labeling with GFP retroviruses, lentiviruses, and adenoviruses for imaging." In Biomedical Optics (BiOS) 2008, edited by Alexander P. Savitsky, Robert E. Campbell, and Robert M. Hoffman. SPIE, 2008. http://dx.doi.org/10.1117/12.773308.
Full textTulio, Robertha, and Rômulo Machado Balmant. "Dental care for HIV positive patients - care and importance - case report." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-087.
Full textTapanes-Castillo, Alexis, Derek Dykxhoorn, Leana Ramos, Milagros Mulero, Deliabell Hernandez, and Vadym Trokhymchuk. "Culturing Human Neural Stem Cells and Quantifying Lentiviruses to Study Autism." In MOL2NET 2016, International Conference on Multidisciplinary Sciences, 2nd edition. Basel, Switzerland: MDPI, 2016. http://dx.doi.org/10.3390/mol2net-02-07008.
Full textAlton, EWFW, AC Boyd, JC Davies, DR Gill, U. Griesenbach, TE Harman, SC Hyde, and G. McLachlan. "S68 Towards a first-in-human trial with a pseudotyped lentivirus." In British Thoracic Society Winter Meeting, Wednesday 17 to Friday 19 February 2021, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2021. http://dx.doi.org/10.1136/thorax-2020-btsabstracts.73.
Full textLund-Palau, H., C. Meng, A. Pilou, N. Atsumi, A. Bhargava, M. Chan, A. Byrne, et al. "T2 Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis." In British Thoracic Society Winter Meeting 2018, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 5 to 7 December 2018, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2018. http://dx.doi.org/10.1136/thorax-2018-212555.2.
Full textBurke, David, Kristine Drafahl, Clark Fjeld, Chad Galderisi, and Cindy Spittle. "Abstract 896: Enhanced sensitivity detection of replication competent lentivirus by qPCR." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-896.
Full textWilson, AA, GJ Murphy, H. Hamakawa, L. Kwok, S. Srinivasan, A. Hovav, RC Mulligan, S. Amar, B. Suki, and DN Kotton. "Lentivirus-Based Expression of Human Alpha-1 Antitrypsin Ameliorates Emphysema in Mice." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3509.
Full textMarcotte, Richard, Azin Sayad, Maliha Haider, Kevin Brown, Troy Ketela, Jason Moffat, and Benjamin G. Neel. "Abstract PR01: Functional characterization of breast cancer using pooled lentivirus shRNA screens." In Abstracts: AACR Precision Medicine Series: Synthetic Lethal Approaches to Cancer Vulnerabilities - May 17-20, 2013; Bellevue, WA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.pms-pr01.
Full textMarcotte, Richard, Kevin Brown, Azin Sayad, Maliha Haider, Troy Ketela, Jason Moffat, and Benjamin G. Neel. "Abstract 5084: Functional genomic classification of breast cancer using pooled lentivirus shRNA screens." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5084.
Full textReports on the topic "Lentivirusus"
Lindner, Daniel. Complementation of Myelodysplastic Syndrome Clones with Lentivirus Expression Libraries. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada566912.
Full textLindner, Daniel J. Complementation of Myelodysplastic Syndrome Clones with Lentivirus Expression Libraries. Fort Belvoir, VA: Defense Technical Information Center, January 2013. http://dx.doi.org/10.21236/ada581503.
Full textLindner, Daniel. Complementation of Myelodysplastic Syndrome Clones with Lentivirus Expression Libraries. Fort Belvoir, VA: Defense Technical Information Center, July 2011. http://dx.doi.org/10.21236/ada581646.
Full textDeMartini, James C., Abraham Yaniv, Jonathan O. Carlson, Arnona Gazit, Leonard E. Pearson, Kalman Perk, J. K. Young, Noam Safran, and A. Friedman. Evaluation of Naked Proviral DNA as a Vaccine for Ovine Lentivirus Infection. United States Department of Agriculture, September 1994. http://dx.doi.org/10.32747/1994.7570553.bard.
Full text